Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Point-of-Care Molecular Diagnostics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Point-of-Care Molecular Diagnostics Market, by Application, 2019-2029 (USD Billion)
1.2.3. Point-of-Care Molecular Diagnostics Market, by Technology, 2019-2029 (USD Billion)
1.2.4. Point-of-Care Molecular Diagnostics Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Point-of-Care Molecular Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Point-of-Care Molecular Diagnostics Market Dynamics
3.1. Point-of-Care Molecular Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of chronic diseases
3.1.1.2. Rising Demand for Point-of-care Diagnostics
3.1.2. Market Challenges
3.1.2.1. A lack of high-complexity test centres in POC molecular testing
3.1.2.2. Uncertain reimbursement scenarios
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
3.1.3.2. Investments in the R&D centre
Chapter 4. Global Point-of-Care Molecular Diagnostics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Point-of-Care Molecular Diagnostics Market, by Application
6.1. Market Snapshot
6.2. Global Point-of-Care Molecular Diagnostics Market by Application, Performance - Potential Analysis
6.3. Global Point-of-Care Molecular Diagnostics Market Estimates & Forecasts by Application, 2019-2029 (USD Billion)
6.4. Point-of-Care Molecular Diagnostics Market, Sub Segment Analysis
6.4.1. Oncology
6.4.2. Infectious Diseases
6.4.3. Hematology
6.4.4. Endocrinology
6.4.5. Other Applications
6.4.6. Prenatal Testing
Chapter 7. Global Point-of-Care Molecular Diagnostics Market, by Technology
7.1. Market Snapshot
7.2. Global Point-of-Care Molecular Diagnostics Market by Technology, Performance - Potential Analysis
7.3. Global Point-of-Care Molecular Diagnostics Market Estimates & Forecasts by Technology, 2019-2029 (USD Billion)
7.4. Point-of-Care Molecular Diagnostics Market, Sub Segment Analysis
7.4.1. PCR
7.4.2. Genetic Sequencing
7.4.3. Hybridization
7.4.4. Microarray
Chapter 8. Global Point-of-Care Molecular Diagnostics Market, by End-User
8.1. Market Snapshot
8.2. Global Point-of-Care Molecular Diagnostics Market by End-User, Performance - Potential Analysis
8.3. Global Point-of-Care Molecular Diagnostics Market Estimates & Forecasts by End-User, 2019-2029 (USD Billion)
8.4. Point-of-Care Molecular Diagnostics Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Homecare
8.4.3. Other End-Users
Chapter 9. Global Point-of-Care Molecular Diagnostics Market, Regional Analysis
9.1. Point-of-Care Molecular Diagnostics Market, Regional Market Snapshot
9.2. North America Point-of-Care Molecular Diagnostics Market
9.2.1. U.S. Point-of-Care Molecular Diagnostics Market
9.2.1.1. Application breakdown estimates & forecasts, 2019-2029
9.2.1.2. Technology breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Point-of-Care Molecular Diagnostics Market
9.3. Europe Point-of-Care Molecular Diagnostics Market Snapshot
9.3.1. U.K. Point-of-Care Molecular Diagnostics Market
9.3.2. Germany Point-of-Care Molecular Diagnostics Market
9.3.3. France Point-of-Care Molecular Diagnostics Market
9.3.4. Spain Point-of-Care Molecular Diagnostics Market
9.3.5. Italy Point-of-Care Molecular Diagnostics Market
9.3.6. Rest of Europe Point-of-Care Molecular Diagnostics Market
9.4. Asia-Pacific Point-of-Care Molecular Diagnostics Market Snapshot
9.4.1. China Point-of-Care Molecular Diagnostics Market
9.4.2. India Point-of-Care Molecular Diagnostics Market
9.4.3. Japan Point-of-Care Molecular Diagnostics Market
9.4.4. Australia Point-of-Care Molecular Diagnostics Market
9.4.5. South Korea Point-of-Care Molecular Diagnostics Market
9.4.6. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market
9.5. Latin America Point-of-Care Molecular Diagnostics Market Snapshot
9.5.1. Brazil Point-of-Care Molecular Diagnostics Market
9.5.2. Mexico Point-of-Care Molecular Diagnostics Market
9.6. Rest of The World Point-of-Care Molecular Diagnostics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Meridian Bioscience Inc
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbott Laboratories
10.2.3. Siemens Healthineers
10.2.4. F. Hoffmann-La Roche Ltd
10.2.5. Becton, Dickinson, and Company
10.2.6. Danaher Corporation
10.2.7. BioMerieux
10.2.8. Agilent Technologies
10.2.9. OraSure Technologies Inc.
10.2.10. Thermo Fisher Scientific
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption